A group of 35 biotech associations sent a letter to Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) warning that their plan to redesign Medicare Part D could have a "chilling effect" on specialty drug innovation.
Pharmacy
The HHS Office of Inspector General found during an audit to determine whether Medicare Part D sponsors correctly reported pharmacy fees that Geisinger didn't report its point-of-sale fees for three years.
Costco and delivery startup Instacart are joining forces to test a prescription drug delivery service, according to CNBC.
Aetna boosted CVS Health's profits by 10 percent in the third fiscal quarter, according to CNBC.
CVS Health plans to close 22 "underperforming" drugstores in early 2020, adding to the 46 stores it closed earlier this year, according to CNBC.
Advertisement
With the United States Pharmacopeia (USP) General Chapter <800> becoming official in December 2019, ensuring compliance is top-of-mind for many hospitals, health systems and pharmacies as poor adherence to the regulations can harm staff health.
Memorial Hospital at Gulfport (Miss.) has rolled out a specialty pharmacy program to make complex and expensive drugs more accessible to patients.
Sanofi has agreed to pay $315 million to settle claims that it slowed the development of a multiple sclerosis drug to avoid paying investors after the company acquired Genzyme Corp.
Walgreens Boots Alliance is exploring a deal that would take the company private, according to CNBC.
The Office of Management and Budget is reviewing a rule that would allow the U.S. to import certain drugs from Canada and other countries as a strategy to lower drug costs, according to Regulatory Focus.